← Evidence map

ReviewPsoriasis (Auckland, N.Z.)

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis.

Sahil Sekhon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 29387609